课题基金 / 基金详情

The EMERGEncy ID NET Study Group

The EMERGEncy ID NET Study Group
EMERGEncy ID NET 研究小组
批准号:
10155370
负责人:
DAVID ANDREW TALAN
金额:
$369.05万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2021-04-30

项目摘要

项目成果

DAVID ANDREW TALAN的其他基金

相似基金

相关文献

中文摘要
翻译
项目概要 EMERGEncy ID NET 是一个用于监测和研究新发传染病的哨兵网络 疾病。它由 11 个数量大、地域多样、学术相关的 美国的急诊部门。 EMERGEncy ID NET 于 1995 年创建 响应疾病控制和预防中心 (CDC) 的战略计划,以加强 使用新方法的监督机制。 CDC 合作赠款资助了 过去 20 年中,EMERGEncy ID NET 广泛研究了网络 感染,并已成为创建多中心、基于临床综合征的模型 研究网络。研究网络继续成功地解决了威胁 通过评估疾病流行率、风险因素和管理来识别新出现的传染病 社区中不同人群进行尖锐演讲的做法 急诊科。许多经过同行评审的出版物均来自 EMERGEncy ID NET 在期刊上的研究,包括《新英格兰医学杂志》、 JAMA、临床传染病、新发传染病和紧急情况年鉴 医学。 EMERGEncy ID NET 计划计划继续与 CDC 合作,开展 对美国各种新出现和流行的感染的持续调查。这个 将通过以下方式完成:1)确定紧急情况中新出现和流行的感染 科室病人; 2)制定研究目标和材料以进行前瞻性研究 研究; 3) 获得必要的批准以进行人类受试者的研究 保护委员会; 4)通过紧急情况的入组和随访来实施研究 科室病人; 5)管理收集的数据; 6) 产生研究结果 在同行评审出版物和科学会议上报告我们的发现;和 7) 扩大网络,让更多的急诊部门参与进来,以提高我们的能力 将我们的发现推广到美国的其他人群。 过去 20 年来 EMERGEncy ID NET 计划所取得的成就表明 其快速解决各种紧急公共卫生传染病问题的能力 有效地将调查结果传播到传染病、公共卫生、 急诊医学从业者和公众。紧急身份识别网调查人员已 一些正在进行的和新的项目计划解决当前和预期的新兴问题 感染威胁。
英文摘要
Project Summary EMERGEncy ID NET is a sentinel network for surveillance and research of emerging infectious diseases. It is comprised of 11 high-volume, geographically-diverse, and academically-affiliated emergency departments in the United States. EMERGEncy ID NET was created in 1995 in response to the Centers for Disease Control and Prevention's (CDC) strategic plan to enhance surveillance mechanisms using novel approaches. A CDC cooperative grant has funded the network for the last 20 years during which EMERGEncy ID NET has studied a wide range of infections and has been a model for the creation of multi-center, clinical syndrome-based research networks. The research network has continued to successfully address the threat of emerging infectious diseases by assessing disease prevalence, risk factors, and management practices for acute presentations from the community among a diverse population presenting to emergency departments. Numerous peer-reviewed publications have resulted from EMERGEncy ID NET research in journals that include The New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Emerging Infectious Diseases, and Annals of Emergency Medicine. The EMERGEncy ID NET program plans to continue collaboration with the CDC to conduct ongoing investigations of various emerging and prevalent infections in the United States. This will be accomplished by: 1) identifying emerging and prevalent infections among emergency department patients; 2) developing study objectives and materials to conduct prospective studies; 3) obtaining necessary approvals to conduct the research from Human Subject Protection Committees; 4) implementing studies through enrollment and follow-up of emergency department patients; 5) managing data collected; 6) generating results from studies and reporting our findings in peer-reviewed publications and at scientific conferences; and 7) expanding the network to involve more emergency departments to improve our capability of generalizing our findings to additional populations in the United States. The accomplishments of the EMERGEncy ID NET program over the past 20 years demonstrate its capability to rapidly address a variety of urgent public health infectious disease problems and propagate the results of investigations effectively to infectious disease, public health, emergency medicine practitioners, and the public. EMERGEncy ID NET investigators have several ongoing and new projects planned to address current and anticipated emerging infection threats.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
RFA-CK-22-003, Emerging Infections Sentinel Networks (EISN) Research - 2022
国内基金
海外基金
ID2驱动的生物钟紊乱通过PI3K-AKT信号轴调控前列腺癌细胞异质性和可塑性的研究
  • 批准号:
    JCZRLH202600193
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
Id2在胶质母细胞瘤中的作用及Id2/Oligo2促进胶质母细胞瘤EMT的分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    彭灿
  • 依托单位:
清肺合剂上调丁酸调控 HDACs/ID2/IL-12R 通 路增强 PD-1 抑制剂抗肺癌作用的机制研究
  • 批准号:
    Q24H290030
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    陈卓
  • 依托单位:
DRAL-Id3 轴在造血应激状态下调控 HSCs 自 我更新的分子机制研究
  • 批准号:
    Y24H080015
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    陈一瑞
  • 依托单位: